Latest news
Archana Subramanya appointed Head of R&D India Hub at Sanofi - Indian Pharma PostIndian Pharma Post · Thu, 06 Aug 2026 13:00:00 GMTSanofi India Cuts Operating Expenses By 5% In Q2 And 15% In H1 YTD - SahiSahi · Thu, 06 Aug 2026 05:15:54 GMTSanofi India Ltd (BOM:500674) (Q2 2027) Earnings Call Highlights: Diabetes Portfolio Drives 14% ... - Yahoo! Finance CanadaYahoo! Finance Canada · Wed, 05 Aug 2026 19:00:33 GMTSanofi India net profit rises 20% in Q1FY27 to ₹835 million - scanx.tradescanx.trade · Wed, 05 Aug 2026 08:21:22 GMTSanofi India standalone net profit rises 20.14% in the June 2026 quarter - Business StandardBusiness Standard · Wed, 05 Aug 2026 03:50:22 GMTSanofi India profit before tax rises 19% to ₹1,123 crore in Q2FY26 - scanx.tradescanx.trade · Tue, 04 Aug 2026 17:36:25 GMTSanofi India Limited Revenue Breakdown – NSE:SANOFI - TradingViewTradingView · Thu, 30 Jul 2026 21:24:27 GMTSanofi Consumer Healthcare India reports 7% revenue growth in Q2 FY26; PBT rises 16% - Indian Pharma PostIndian Pharma Post · Wed, 29 Jul 2026 03:07:05 GMT